Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 447-461
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic Dermatitis
Jonathan Bar, Ester Del Duca, Eden David, et al.
Allergy (2025)
Closed Access | Times Cited: 1
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 587-587
Open Access | Times Cited: 8
A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis
Katarzyna Waligóra-Dziwak, Aleksandra Dańczak‐Pazdrowska, Dorota Jenerowicz
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4001-4001
Open Access | Times Cited: 8
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
José Miguel Alvarenga, Thomas Bieber, Tiago Torres
Drugs (2024)
Open Access | Times Cited: 7
Emerging Systemic Treatment Options in Atopic Dermatitis
Andaç Salman, Ana M. Giménez‐Arnau
Balkan Medical Journal (2024), pp. 239-247
Open Access | Times Cited: 4
Pediococcus pentosaceus CCFM1402 Could Repair Skin Barrier via AHR-OVOL1 Pathway and OX40 Receptor Modulation
Baojing Ren, Bingyong Mao, Xin Tang, et al.
Food Bioscience (2025), pp. 105852-105852
Closed Access
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
Ayaka Sato, Hodaka Nagai, Ayano Suzuki, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
HVEM as a Tumor-Intrinsic Regulator in Non-Small Cell Lung Cancer: Suppression of Metastasis via Glycolysis Inhibition and Modulation of Macrophage Polarization
Yuanshan Yao, Bin Li, Chunji Chen, et al.
Pharmacological Research (2025), pp. 107604-107604
Open Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
Emma Guttman‐Yassky, Eric L. Simpson, Robert Bissonnette, et al.
Immunotherapy (2025), pp. 1-12
Open Access
Large‐Scale Plasma Proteomics to Profile Pathways and Prognosis of Chronic Pain
Zeyu Li, Qing Ma, Jie Zhang, et al.
Advanced Science (2025)
Open Access
Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives
Yuxin Shi, Hao Zhang, Changhong Miao
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Safety and Efficacy of Anti-OX40 Therapies in Atopic Dermatitis: A Systematic Review and Meta-Analysis
Helen Michaela de Oliveira, Mariano Gallo Ruelas, César Antonio González-Díaz, et al.
Dermatitis (2025)
Closed Access
Exploring the shared genetic mechanisms of atopic dermatitis and alopecia areata via bioinformatics approaches
Qianqian Chen, Ting Yang, Jiayi Cheng, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
High-Purity Preparation and Biophysical Characterization of OX40-TC in Lipid Nanodiscs
Hao Wang, Xiaohui Zhang, Cunlong Yin, et al.
Protein Expression and Purification (2025) Vol. 230, pp. 106697-106697
Closed Access
Network pharmacology and in silico analysis reveal Kochiae Fructus as a potential therapeutic against atopic dermatitis through immunomodulatory pathway interactions
Shakeel Ahmad Khan
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320818-e0320818
Open Access
American Academy of Dermatology Annual Meeting: Orlando, FL, USA, 7-11 March 2025
Kathy A Fraser
American Journal of Clinical Dermatology (2025)
Closed Access
A Reliable Prognostic Model for Hepatocellular Carcinoma Using Neutrophil extracellular traps and immune Related Genes
Dahua Yuan, Feng Zhang, Pengfei Lv, et al.
Research Square (Research Square) (2025)
Closed Access
Innovations and Emerging Therapies in Atopic Dermatitis Part 1
Robyn Okereke, Eric L. Simpson
Current Treatment Options in Allergy (2025) Vol. 12, Iss. 1
Closed Access
Atopic dermatitis: pathogenesis and therapeutic intervention
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Transdermal delivery of natural products against atopic dermatitis
Minghui Li, Yihua Xu, Yamei Yu, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 12, pp. 1076-1088
Closed Access | Times Cited: 2
Monoklonale Antikörper für entzündliche, autoimmune und onkologische Hauterkrankungen
Maria Kinberger, Gábor Dobos, Farzan Solimani
Deleted Journal (2024)
Closed Access | Times Cited: 1
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
Stephan Weidinger, Andrew Blauvelt, Kim Papp, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top